Trademark Attorney / Law Firm

Paul Rees – Trademark Portfolio

Paul Rees specializes in Class 5 (Pharmaceuticals) trademark filings before the United States Patent and Trademark Office (USPTO), with 4 of 6 total filings concentrated in this category. The practice also covers Class 42 (Computer & Scientific) along with 3 other Nice Classification classes. Filing activity spans from 2014 to 2015. Currently, 0 trademarks are registered.

6 Total Trademarks
Loading...
By Date
By Name
Filter by Class:

Practice Areas by Trademark Class

Paul Rees's trademark practice covers 3 Nice Classification classes, representing the range of industries and goods/services handled in their USPTO filings.

5
Pharmaceuticals (4 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

42
Computer & Scientific (1 filing)

Scientific and technological services; industrial analysis and research services

30
Staple Foods (1 filing)

Coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations

Frequently Asked Questions

How many trademark applications has Paul Rees filed?

Paul Rees has filed 6 trademark applications with the United States Patent and Trademark Office (USPTO).

What trademark classes does Paul Rees specialize in?

Paul Rees has filed trademarks across 3 Nice Classification classes. The most common practice areas include Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 30 (Staple Foods). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

How long has Paul Rees been filing trademarks?

Paul Rees's trademark filing history with the USPTO spans from 2014 to 2015, covering 1 year of trademark practice. During this period, Paul Rees has handled 6 trademark applications.

What is Paul Rees's trademark registration success rate?

Paul Rees has a 0% trademark registration rate, with 0 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.